FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979548907> ?p ?o ?g. }

• W1979548907 abstract "Breast cancer is a complex and heterogeneous disease and one of the most frequent causes of cancer deaths in developed countries. DNA copy number alterations occur frequently in breast tumours. Regions of DNA amplification are of major interest since often contain oncogenes whose increased expression confers tumour cells a selective advantage and contributes to the carcinogenesis process. In our laboratory prior analysis of familiar and sporadic breast tumours by using array-CGH identified an amplification event at the 13q34 region with an overall frequency of 4.5% that increased to 8.1% in BRCA1-associated tumours. Comprehensive characterization of the amplicon allowed us to define CUL4A as one of the most likely putative oncogenes. CUL4A is an E3 Ubiquitin Ligase which is amplified and/or overexpressed in primary breast tumours and involved in functions such as chromatin regulation, cell cycle regulation or DNA repair through ubiquitylation of NER pathway members. Its deregulation could have implications for oncogenic transformation and treatment response to DNA-damaging agents. One of such compounds is Trabectedin a marine-derived drug that presents antitumor activity in sarcomas and ovarian cancer. To elucidate the possible implication of CUL4A in the initial steps of the tumorigenic process we conducted the stable up-regulation of CUL4A in human mammary epithelial cells (184B5), and in NIH3T3 mouse-derived cell line by lentiviral infection. We also stably silenced CUL4A in the human breast cancer cell lines MDA-MB-157 and HCC1937 that present amplification and/or overexpression of CUL4A. With these modified cell lines we performed functional assays in different in vitro systems such as viability experiments, colony formation both in plastic and in soft agar and 3-D cultures in Matrigel. In order to measure sensitivity to Trabectedin we used silenced CUL4A breast cancer cell lines to perform clonogenic assays. Our preliminary results in CUL4A overexpression in 184B5 model system showed increase in proliferation and colony formation ability. On the other hand, CUL4A silencing in breast cancer cell lines resulted in diminished proliferation and decreased colony-forming abilities in both anchorage dependent and independent conditions. Concerning DNA-repair implication, it seems that high levels of CUL4A could be a good predictor of Trabectedin response. Our results indicate that CUL4A would play a role in promoting oncogenesis and/or in modulating breast cancer progression. Further evaluation of CUL4A amplification/overexpression impact on the maintenance of genome integrity will help elucidate its full potential for therapeutic intervention in breast and other cancers. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 91. doi:1538-7445.AM2012-91" @default.
• W1979548907 created "2016-06-24" @default.
• W1979548907 creator A5010374726 @default.
• W1979548907 creator A5019988011 @default.
• W1979548907 creator A5035296945 @default.
• W1979548907 creator A5050877302 @default.
• W1979548907 creator A5052211470 @default.
• W1979548907 creator A5061750530 @default.
• W1979548907 creator A5076881555 @default.
• W1979548907 creator A5081381927 @default.
• W1979548907 creator A5082106706 @default.
• W1979548907 date "2012-04-15" @default.
• W1979548907 modified "2023-10-18" @default.
• W1979548907 title "Abstract 91: The CUL4A ubiquitin ligase, a putative target gene at the 13q34 amplicon and its role in breast cancer pathogenesis & progression" @default.
• W1979548907 doi "https://doi.org/10.1158/1538-7445.am2012-91" @default.
• W1979548907 hasPublicationYear "2012" @default.
• W1979548907 type Work @default.
• W1979548907 sameAs 1979548907 @default.
• W1979548907 citedByCount "0" @default.
• W1979548907 crossrefType "proceedings-article" @default.
• W1979548907 hasAuthorship W1979548907A5010374726 @default.
• W1979548907 hasAuthorship W1979548907A5019988011 @default.
• W1979548907 hasAuthorship W1979548907A5035296945 @default.
• W1979548907 hasAuthorship W1979548907A5050877302 @default.
• W1979548907 hasAuthorship W1979548907A5052211470 @default.
• W1979548907 hasAuthorship W1979548907A5061750530 @default.
• W1979548907 hasAuthorship W1979548907A5076881555 @default.
• W1979548907 hasAuthorship W1979548907A5081381927 @default.
• W1979548907 hasAuthorship W1979548907A5082106706 @default.
• W1979548907 hasConcept C104317684 @default.
• W1979548907 hasConcept C121608353 @default.
• W1979548907 hasConcept C134459356 @default.
• W1979548907 hasConcept C25602115 @default.
• W1979548907 hasConcept C29537977 @default.
• W1979548907 hasConcept C49105822 @default.
• W1979548907 hasConcept C502942594 @default.
• W1979548907 hasConcept C530470458 @default.
• W1979548907 hasConcept C54355233 @default.
• W1979548907 hasConcept C555283112 @default.
• W1979548907 hasConcept C7602840 @default.
• W1979548907 hasConcept C8185291 @default.
• W1979548907 hasConcept C83640560 @default.
• W1979548907 hasConcept C86803240 @default.
• W1979548907 hasConceptScore W1979548907C104317684 @default.
• W1979548907 hasConceptScore W1979548907C121608353 @default.
• W1979548907 hasConceptScore W1979548907C134459356 @default.
• W1979548907 hasConceptScore W1979548907C25602115 @default.
• W1979548907 hasConceptScore W1979548907C29537977 @default.
• W1979548907 hasConceptScore W1979548907C49105822 @default.
• W1979548907 hasConceptScore W1979548907C502942594 @default.
• W1979548907 hasConceptScore W1979548907C530470458 @default.
• W1979548907 hasConceptScore W1979548907C54355233 @default.
• W1979548907 hasConceptScore W1979548907C555283112 @default.
• W1979548907 hasConceptScore W1979548907C7602840 @default.
• W1979548907 hasConceptScore W1979548907C8185291 @default.
• W1979548907 hasConceptScore W1979548907C83640560 @default.
• W1979548907 hasConceptScore W1979548907C86803240 @default.
• W1979548907 hasLocation W19795489071 @default.
• W1979548907 hasOpenAccess W1979548907 @default.
• W1979548907 hasPrimaryLocation W19795489071 @default.
• W1979548907 hasRelatedWork W1567196592 @default.
• W1979548907 hasRelatedWork W1606452383 @default.
• W1979548907 hasRelatedWork W1939696168 @default.
• W1979548907 hasRelatedWork W1963744941 @default.
• W1979548907 hasRelatedWork W1965384489 @default.
• W1979548907 hasRelatedWork W1966236033 @default.
• W1979548907 hasRelatedWork W2038918331 @default.
• W1979548907 hasRelatedWork W2045815695 @default.
• W1979548907 hasRelatedWork W2067852461 @default.
• W1979548907 hasRelatedWork W2096586295 @default.
• W1979548907 hasRelatedWork W2114479856 @default.
• W1979548907 hasRelatedWork W2262058710 @default.
• W1979548907 hasRelatedWork W2294085616 @default.
• W1979548907 hasRelatedWork W2324569776 @default.
• W1979548907 hasRelatedWork W2325275208 @default.
• W1979548907 hasRelatedWork W2461937652 @default.
• W1979548907 hasRelatedWork W2759624873 @default.
• W1979548907 hasRelatedWork W2907390836 @default.
• W1979548907 hasRelatedWork W2968075657 @default.
• W1979548907 hasRelatedWork W2978619511 @default.
• W1979548907 isParatext "false" @default.
• W1979548907 isRetracted "false" @default.
• W1979548907 magId "1979548907" @default.
• W1979548907 workType "article" @default.